Senior insider sale
TG THERAPEUTICS, INC. — senior position signals high conviction
$814.5K
34.85K shares
What this filing means
LONIAL SAGAR plans to sell 34.85K shares of TG THERAPEUTICS, INC. valued at approximately $814.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/23/2023ACC: 0001959173-23-002082
34.85K
Shares to sell
$814.5K
Approx. market value
34.85K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
6/22/2023
34.85KTotal acquired34.85K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/22/2023 | Restricted Stock Vesting Compensation | 34.85K | — |
| Total | 34.85K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
34.85K
Market value
$814.5K
6/23/2023
Total
Units
34.85K
Value
$814.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/23/2023 | 34.85K | $814.5K | NASDAQ | Planned |
| Total | 34.85K | $814.5K | ||